Furthermore, this study confirmed that the anti-PSMA antibody functionalized PSMA-targeting GNPs are effective radiosensitizers for prostate cancer cells through a clonogenic assay and γ-H2AX assay. Here, FOLH1 is linked to prostate carcinoma.